This Project Grant award of $473,377 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, supports research to modulate the stem cell niche and improve skeletal muscle regeneration. The key objectives are to: Interrogate how muscle cells arise and develop functional characteristics from human pluripotent stem cells (hPSCs) through analysis of myogenic commitment factors and inhibition of...
This Project Grant award of $626,483.00, granted by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research to determine the role of netrin-1 signaling in regulating muscle stem cell quiescence and activation. The research will use a combination of in vivo and ex vivo techniques, including tissue clearing, live imaging of muscle stem cells within muscle bundles,...
This $420,883 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support research to improve muscle regeneration and restore function following serious traumatic injuries. The University of Missouri System, the prime recipient, will leverage its expertise in microvascular imaging, muscle biology, and biomaterials to investigate the role of fibroadipogenic...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $177,872 to the University of Houston System to study the interaction between human induced pluripotent stem cell (hiPSC)-derived endothelial cells and skeletal muscle progenitor cells, both in vitro and in vivo. The research aims to elucidate the underlying mechanisms governing the...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, CFDA 93.846) provides $248,724 to the University of Alabama at Birmingham (UAB) to conduct research on the role of cellular senescence in skeletal muscle loss and dysfunction. The overarching objectives are to (1) obtain the necessary skills and training to develop a translational research program investigating mechanisms underlying skeletal muscle wasting, and (2) generate data to...
This federal Project Grant award R01AG087565 from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,343,725.00 to investigate the opposing effects of extracellular matrix aging and muscle activity on extracellular vesicle promotion of muscle regeneration. The award period runs from August 15, 2024 to April 30, 2029. The key objectives are to: 1) Examine how aging of the skeletal muscle extracellular matrix alters the molecular cargoes of muscle-derived extracellular...
This $439,791 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research at The University of Texas Southwestern Medical Center to investigate the molecular mechanisms underlying myoblast fusion, the process by which muscle precursor cells fuse to form mature muscle fibers. The research aims to gain a deeper understanding of the actin...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,905,716.00 to New York University School of Medicine to support research into the molecular mechanisms regulating the inflammatory response in skeletal stem and progenitor cells (SSPCs) and the role of anti-inflammatory factors in resolving inflammation. The goal is to determine how these mechanisms and the interaction between pro- and anti-inflammatory signals are affected by aging, with the...
This $692,292 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund research to understand the regulation of pediatric muscle regeneration and its implications for treating muscle diseases such as Duchenne muscular dystrophy (DMD). The 5-year project, running from April 2025 to March 2030, will be conducted by the Children's...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to investigate the cellular and molecular mechanisms driving regeneration and fibrosis of the tendon-bone attachment, or enthesis. The $317,211 award to The General Hospital Corporation (doing business as Massachusetts General Hospital) will support research to identify the key factors that...
PROTEASE-MEDIATED REGULATION OF STEM CELL NICHE REMODELING - SUMMARY SKELETAL MUSCLE IS THE MOST ABUNDANT TISSUE IN THE HUMAN BODY, WITH A WIDE RANGE OF FUNCTIONS, FROM LOCOMOTION TO BREATHING, VISION, BLOOD PRESSURE CONTROL, METABOLISM, AND ENDOCRINE REGULATION. MUSCLE HOMEOSTASIS AND REGENERATION ARE LARGELY DEPENDENT ON A SMALL POPULATION OF STEM CELLS THAT RESIDE QUIESCENT IN THE MUSCLE TISSUE UNTIL ACTIVATED BY A STIMULUS, TYPICALLY AN INJURY. TIGHT REGULATION OF THE ACTIVATION PROCESS IS ESSENTIAL FOR TISSUE HOMEOSTASIS: TOO LITTLE ACTIVATION WOULD IMPAIR THE TISSUE'S ABILITY TO REGENERATE IN RESPONSE TO DAMAGE, WHILE TOO MUCH ACTIVATION COULD LEAD TO TUMOR FORMATION OR PREMATURE DEPLETION OF THE STEM CELL POOL. NEUTROPHILS ATTRACTED TO INJURED MUSCLE SECRETE PROTEOLYTIC ENZYMES, AND WE HAVE RECENTLY OBSERVED THAT ONE SUCH ENZYME, NEUTROPHIL ELASTASE, APPEARS TO PROMOTE MUSCLE STEM CELL ACTIVATION. MOREOVER, WE HAVE OBSERVED THAT TRIPLE KNOCKOUT OF ALL THREE NEUTROPHIL SERINE PROTEASES PRACTICALLY ABROGATES MUSCLE REGENERATION IN RESPONSE TO ACUTE INJURY. THE OVERREACHING GOAL OF THIS PROPOSAL IS TO INVESTIGATE THE PHYSIOLOGICAL FUNCTION OF NEUTROPHIL SERINE PROTEASES IN THE MUSCLE STEM CELL NICHE AND DECIPHER THE UNDERLYING MOLECULAR MECHANISMS. SPECIFICALLY, OUR FIRST AIM IS TO DEFINE HOW THE MUSCLE STEM CELL NICHE AS A WHOLE (CELLS, MATRIX AND SOLUBLE FACTORS) ARE AFFECTED BY LOSS OF EACH NSP AND ALL THREE COMBINED. OUR SECOND AIM IS TO IDENTIFY THE MOLECULAR MECHANISMS THAT ARE REGULATED IN A CELL-AUTONOMOUS MANNER BY THE NSPS IN THE CONTEXT OF MUSC ACTIVATION AND FIRST DIVISION. FINALLY, OUR THIRD AND LAST AIM IS TO VALIDATE IN VITRO AND IN VIVO THE CANDIDATE BIOLOGICAL FUNCTIONS DISCOVERED IN AIM 1 AND 2. IN CONCLUSION, WE EXPECT THAT, IN ADDITION TO ANSWERING THE MAIN QUESTION OF WHICH PROCESSES AND MECHANISMS NEUTROPHIL SERINE PROTEASES REGULATE DURING MUSCLE REGENERATION, AND HOW, THE RESULTS FROM THIS WORK WILL PROVIDE A PLATFORM FOR FUTURE INVESTIGATIONS INTO HOW STEM CELL NICHES ARE CONTINUOUSLY REMODELED BY PROTEASES TO ENSURE PROMPT AND EFFICIENT REGENERATION AS WELL AS STEM CELL AND TISSUE HOMEOSTASIS.